+43-123-13-985|info@ces.b2sg.org

Postdoc – Immune Oncology

By | 2018-03-16T09:25:17+00:00 March 16th, 2018|

Position Highlights:  Individuals in this position will participate in ongoing laboratory and clinical studies to define mechanisms and impact of epigenetic agents on immunotherapy response. Studies will include in-depth mechanistic approaches to define underlying molecular mechanisms, as well as studies in mouse models of lung cancer and patient clinical samples.  The Ideal Candidate:  Will have [...]

Update on the Cancer Epigenetics Clinical Trials Database

By | 2017-05-19T11:28:44+00:00 August 17th, 2016|News|

The Cancer Epigenetics Society has continued expanding its cancer epigenetic drug clinical trial repository which now covers 500+ clinical trials. These include most if not all reported completed, ongoing, and recruiting cancer clinical trials on DNA methyltransferases (DNMTi), histone deacetylases (HDACi), histone methyltransferases (HMTi), and histone demethylases (KDMi). All databases are currently freely accessible to [...]